Quantification of atrial tachyarrhythmia burden with an implantable pacemaker before and after pulmonary vein isolation

PACE - Pacing and Clinical Electrophysiology

Volumn 27, Issue 9, 2004, Pages 1277-1283

  Pürerfellner, Helmut ^a,c   Aichinger, Josef ^a   Martinek, Martin ^a   Nesser, Hans Joachim ^a   Ziegler, Paul ^b   Koehler, Jodi ^b   Warman, Eduardo ^b   Hettrick, Douglas ^b  

^a ELISABETHINEN HOSPITAL   (Austria)

^b MEDTRONIC INC   (United States)

^c UNIVERSITY OF INNSBRUCK   (Austria)

Author keywords

Ablation; Atrial fibrillation; Pulmonary veins; Quality of life

Indexed keywords

ADULT; AGED; ARTICLE; ARTIFICIAL HEART PACEMAKER; ATRIAL TACHYARRHYTHMIA BURDEN; CLINICAL ARTICLE; DEVICE; FEMALE; HOLTER MONITORING; HUMAN; IMPLANTATION; ISOLATED ORGAN; MALE; MONITORING; PULMONARY VEIN; PULMONARY VEIN ISOLATION; QUALITY OF LIFE; QUANTITATIVE ANALYSIS; SUPRAVENTRICULAR TACHYCARDIA; VEIN SURGERY; WILCOXON SIGNED RANKS TEST;

ATRIAL FIBRILLATION; CATHETER ABLATION; FEMALE; HUMANS; MALE; MIDDLE AGED; PACEMAKER, ARTIFICIAL; PULMONARY VEINS; QUALITY OF LIFE;

EID: 4644277592     PISSN: 01478389     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1540-8159.2004.00620.x     Document Type: Article

References (14)

1. Haissaguerre M, Shah DC, Jais P, et al. Electrophysiological breakthroughs from the left atrium to the pulmonary veins. Circulation 2000; 102:2463-2465.
2. Chen SA, Hsieh MH, Tai CT, et al. Initiation of atrial fibrillation by ectopic beats originating from the pulmonary veins: Electrophysiological characteristics, pharmacological responses, and effects of radiofrequency ablation. Circulation 1999; 100:1879-1886.
3. Pappone C, Rosanio S, Oreto G, et al. Circumferential radiofrequency ablation of pulmonary vein ostia: A new anatomic approach for curing atrial fibrillation. Circulation 2000; 102:2619-2628.
4. Rose SM, Gillis AM, Sheldon RS. Evaluation of the bias in using the time to first event when inter-event intervals have a Weibull distribution. Stat Med 1999; 18:139-154.
5. Savelieva I, Camm AJ. Clinical relevance of silent atrial fibrillation: Prevalence, prognosis, quality of life and management. J Interv Card Electrophysiol 2000; 4:369-382.
6. Dorian P, Jung W, Newman D, et al. The impairment of health-related quality of life in patients with intermittent atrial fibrillation: Implications for the assessment of investigational therapy. J Am Coll Cardiol 2000; 36:1303-1309.
7. Israel CW, Hugl B, Unterberg C, et al. Pace-termination and pacing for prevention of atrial tachyarrhythmias: Results from a multicenter study with an implantable device for atrial therapy. J Cardiovasc Electrophysiol 2001; 12:1121-1128.
8. Ware JE Jr, Sherbourne CD. The MOS 36-Item Short Form Health Survey (SF-36), I: conceptual framework and item selection. Med Care 1992; 30:473-483.
9. Bubien RS, Knotts-Dolson SM, Plumb VJ, et al. Effect of radiofrequency catheter ablation on health-related quality of life and activities of daily living in patients with recurrent arrhythmias. Circulation 1996; 94:1585-1591.
10. Ruskin J. Trial design in catheter ablation for atrial fibrillation. Boston Atrial Fibrillation Symposium 2003-Mechanisms and new directions in therapy.
11. O'Donnell D, Furniss SS, Dunuwille A, et al. Delayed cure despite early recurrence after pulmonary vein isolation for atrial fibrillation. Am J Cardiol 2003; 91:83-85.
12. Wood MA, Ellenbogen KA, Puererfellner H, et al. Is atrial tachyarrhythmia burden correlated with Quality of Life? (abstract) PACE 2003; 26(Pt II):1036.
13. Israel CW, Grönefeld G, Ehrlich JR, et al. Long term risk of recurrent atrial fibrillation as documented by an implantable monitoring device: Implications for optimal patient care. J Am Coll Cardiol 2004; 43:47-52.
14. Oral H, Scharf C, Chugh A et al. Catheter ablation of paroxysmal atrial fibrillation: Segmental pulmonary vein ostial ablation versus left atrial ablation. Circulation 2003; 108:2355-2360.